Dude, AVH's excuse is that "The reprioritization of hospital resources to support COVID-19 readiness meant that our April results were the lowest monthly revenue and procedural volumes seen this calendar year. " PNV no doubt would have had to deal with the same issue... yet ends the quarter with sales 33% higher than the previous quarter. AVH ends up with no QoQ growth.
"If PNV was so impressive, why have they fallen from above $2.80 down to almost $2.20 in a month?"
If you want to compare share price performance of AVH vs PNV from before the start of COVID through to now, let's take a look. Here is the year to date share price performance in a chart:
PNV is up 15.6% for the year while AVH is down 47.66%. So yeah, one business has certainly been doing a better job at selling products and attracting investors... all without the window dressing of a Nasdaq listing.
Given you own both stocks, I would have thought this had been clear to you, but maybe the picture above will help.
- Forums
- ASX - By Stock
- AVH
- AVH on NASDAQ
AVH on NASDAQ, page-309
-
- There are more pages in this discussion • 635 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.01 |
Change
0.070(2.38%) |
Mkt cap ! $211.9M |
Open | High | Low | Value | Volume |
$3.00 | $3.04 | $2.97 | $754.2K | 251.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 251 | $2.99 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.01 | 2812 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 251 | 2.990 |
1 | 41 | 2.970 |
3 | 20041 | 2.960 |
1 | 10000 | 2.950 |
2 | 20000 | 2.940 |
Price($) | Vol. | No. |
---|---|---|
3.010 | 2812 | 1 |
3.030 | 3006 | 2 |
3.040 | 39707 | 3 |
3.050 | 17312 | 7 |
3.060 | 1224 | 2 |
Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |